Effects of a New Metabolic Conditioning Supplement on Perioperative Metabolic Stress and Clinical Outcomes: A Randomized, Placebo-Controlled Trial

Marzieh Akbarzadeh, Mohammad Hassan Eftekhari, Masih Shafa, Shohreh Alipour, Jafar Hassanzadeh, Marzieh Akbarzadeh, Mohammad Hassan Eftekhari, Masih Shafa, Shohreh Alipour, Jafar Hassanzadeh

Abstract

Background: Insulin resistance is a measure of metabolic stress in the perioperative period. Before now, no clinical trial has determined the summative effects of glutamine, L-carnitine, and antioxidants as metabolic conditioning supplements in the perioperative period.

Objectives: The purpose of this study was to determine the effects of a new conditioning supplement on perioperative metabolic stress and clinical outcomes in non-diabetic patients.

Patients and methods: In this randomized controlled trial, 89 non-diabetic patients scheduled for coronary artery bypass grafting, with ejection fractions above 30%, were selected. Using the balanced block randomization method, the patients were allocated to one of four study arms: 1) SP (supplement/placebo): supplement seven days before and placebo 30 days after the surgery; 2) PS: placebo before and supplement after the surgery; 3) SS: supplement before and after the surgery; and 4) PP: placebo before and after the surgery. The supplement was composed of glutamine, L-carnitine, vitamin C, vitamin E, and selenium, which was manufactured for the first time by this research team. Five blood samples were drawn: seven days preoperatively, at the entrance to the operating room, while leaving the operating room, seven days postoperatively, and 30 days postoperatively. Levels of glucose, insulin, and HbA1c were measured in blood samples. Insulin resistance and sensitivity were calculated using a formula. Surgical complications were assessed 30 days postoperatively. Data analysis was done using one-way ANOVA, the Chi-square test, and a general linear model repeated-measures analysis with Bonferroni adjustment.

Results: Blood glucose levels were increased postoperatively in the four groups (< 0.001), but a significantly higher increase occurred in the PP group compared to the SP (0.027), PS (0.026), and SS (0.004) groups. The superficial wound infection rate was significantly different between the four groups (0.021): 26.08% in PP, 9.09% in SP, 4.54% in PS, and 0% in SS.

Conclusions: Our new metabolic conditioning supplement, whether given pre- or postoperatively, led to better perioperative glycemic control and decreased postsurgical wound infections in non-diabetic patients.

Keywords: Blood Glucose; Infection; Insulin Resistance; Metabolic Stress; Surgery.

Figures

Figure 1.. Flow Diagram of the Trial
Figure 1.. Flow Diagram of the Trial

References

    1. Ljungqvist O. Jonathan E. Rhoads lecture 2011: Insulin resistance and enhanced recovery after surgery. JPEN J Parenter Enteral Nutr. 2012;36(4):389–98. doi: 10.1177/0148607112445580.
    1. Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab. 2010;95(9):4338–44. doi: 10.1210/jc.2010-0135.
    1. Awad S, Lobo DN. Metabolic conditioning to attenuate the adverse effects of perioperative fasting and improve patient outcomes. Curr Opin Clin Nutr Metab Care. 2012;15(2):194–200. doi: 10.1097/MCO.0b013e32834f0078.
    1. Ljungqvist O. Modulating postoperative insulin resistance by preoperative carbohydrate loading. Best Pract Res Clin Anaesthesiol. 2009;23(4):401–9.
    1. Nygren J. The metabolic effects of fasting and surgery. Best Pract Res Clin Anaesthesiol. 2006;20(3):429–38.
    1. Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology. 2009;110(2):408–21. doi: 10.1097/ALN.0b013e3181948a80.
    1. Awad S, Stephenson MC, Placidi E, Marciani L, Constantin-Teodosiu D, Gowland PA, et al. The effects of fasting and refeeding with a ‘metabolic preconditioning’drink on substrate reserves and mononuclear cell mitochondrial function. Clin Nutr . 2010;29(4):538–44.
    1. Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery. 2000;128(5):757–60. doi: 10.1067/msy.2000.107166.
    1. Turina M, Fry DE, Polk HJ. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624–33.
    1. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151–9. doi: 10.2337/db06-0855.
    1. Awad S, Lobo DN. What's new in perioperative nutritional support? Curr Opin Anaesthesiol. 2011;24(3):339–48. doi: 10.1097/ACO.0b013e328345865e.
    1. Grau T, Bonet A, Minambres E, Pineiro L, Irles JA, Robles A, et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med. 2011;39(6):1263–8. doi: 10.1097/CCM.0b013e31820eb774.
    1. Wang Y, Jiang ZM, Nolan MT, Jiang H, Han HR, Yu K, et al. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials. JPEN J Parenter Enteral Nutr. 2010;34(5):521–9. doi: 10.1177/0148607110362587.
    1. Baines M, Shenkin A. Use of antioxidants in surgery: a measure to reduce postoperative complications. Curr Opin Clin Nutr Metab Care. 2002;5(6):665–70. doi: 10.1097/01.mco.0000038810.16540.e0.
    1. Milei J, Ferreira R, Grana DR, Boveris A. Oxidative stress and mitochondrial damage in coronary artery bypass graft surgery: effects of antioxidant treatments. Compr Ther. 2001;27(2):108–16.
    1. Mynatt RL. Carnitine and type 2 diabetes. Diabetes Metab Res Rev. 2009;25 Suppl 1:S45–9. doi: 10.1002/dmrr.987.
    1. Power RA, Hulver MW, Zhang JY, Dubois J, Marchand RM, Ilkayeva O, et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007;50(4):824–32. doi: 10.1007/s00125-007-0605-4.
    1. Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr. 2012;51(1):1–18. doi: 10.1007/s00394-011-0284-2.
    1. Molfino A, Cascino A, Conte C, Ramaccini C, Rossi Fanelli F, Laviano A. Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism. JPEN J Parenter Enteral Nutr. 2010;34(3):295–9. doi: 10.1177/0148607109353440.
    1. Pignatelli P, Tellan G, Marandola M, Carnevale R, Loffredo L, Schillizzi M, et al. Effect of L-carnitine on oxidative stress and platelet activation after major surgery. Acta Anaesthesiol Scand. 2011;55(8):1022–8. doi: 10.1111/j.1399-6576.2011.02487.x.
    1. Awad S, Constantin-Teodosiu D, Constantin D, Rowlands BJ, Fearon KC, Macdonald IA, et al. Cellular mechanisms underlying the protective effects of preoperative feeding: a randomized study investigating muscle and liver glycogen content, mitochondrial function, gene and protein expression. Ann Surg. 2010;252(2):247–53. doi: 10.1097/SLA.0b013e3181e8fbe6.
    1. Singh K, Anderson E, Harper JG. Overview and management of sternal wound infection. Semin Plast Surg. 2011;25(1):25–33. doi: 10.1055/s-0031-1275168.
    1. Salehi Omran A, Karimi A, Ahmadi SH, Davoodi S, Marzban M, Movahedi N, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infect Dis. 2007;7:112. doi: 10.1186/1471-2334-7-112.
    1. Chang HC, Chen CM, Kung SC, Wang CM, Liu WL, Lai CC. Differences between novel and conventional surveillance paradigms of ventilator-associated pneumonia. Am J Infect Control. 2015;43(2):133–6. doi: 10.1016/j.ajic.2014.10.029.
    1. Caljouw MA, van den Hout WB, Putter H, Achterberg WP, Cools HJ, Gussekloo J. Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc. 2014;62(1):103–10.
    1. Akbarzadeh M, Eftekhari MH, Dabbaghmanesh MH, Hasanzadeh J, Bakhshayeshkaram M. Serum IL-18 and hsCRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. Iran J Immunol. 2013;10(3):167–76.
    1. Drover JW, Dhaliwal R, Weitzel L, Wischmeyer PE, Ochoa JB, Heyland DK. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg. 2011;212(3):385–99. doi: 10.1016/j.jamcollsurg.2010.10.016.
    1. Alves WF, Aguiar EE, Guimaraes SB, da Silva Filho AR, Pinheiro PM, Soares Gdos S, et al. L-alanyl-glutamine preoperative infusion in patients with critical limb ischemia subjected to distal revascularization reduces tissue damage and protects from oxidative stress. Ann Vasc Surg. 2010;24(4):461–7. doi: 10.1016/j.avsg.2010.01.005.
    1. Iwashita S, Mikus C, Baier S, Flakoll PJ. Glutamine supplementation increases postprandial energy expenditure and fat oxidation in humans. JPEN J Parenter Enteral Nutr. 2006;30(2):76–80.
    1. Manco M, Calvani M, Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab. 2004;6(6):402–13. doi: 10.1111/j.1462-8902.2004.00356.x.
    1. Ljunggren S, Nystrom T, Hahn RG. Accuracy and precision of commonly used methods for quantifying surgery-induced insulin resistance: Prospective observational study. Eur J Anaesthesiol. 2014;31(2):110–6. doi: 10.1097/EJA.0000000000000017.
    1. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55(5):1430–5.
    1. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 1976;295(8):417–20. doi: 10.1056/NEJM197608192950804.
    1. Al-Niaimi AN, Ahmed M, Burish N, Chackmakchy SA, Seo S, Rose S, et al. Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients. Gynecol Oncol. 2015;136(1):71–6. doi: 10.1016/j.ygyno.2014.09.013.
    1. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37(5):387–97. doi: 10.1016/j.ajic.2008.12.010.
    1. Kao LS, Meeks D, Moyer VA, Lally KP. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev. 2009;(3):CD006806. doi: 10.1002/14651858.CD006806.pub2.
    1. McConnell YJ, Johnson PM, Porter GA. Surgical site infections following colorectal surgery in patients with diabetes: association with postoperative hyperglycemia. J Gastrointest Surg. 2009;13(3):508–15. doi: 10.1007/s11605-008-0734-1.
    1. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10 Suppl 2:21–33. doi: 10.4158/EP.10.S2.21.
    1. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CJ. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607–12. doi: 10.1086/501830.
    1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67. doi: 10.1056/NEJMoa011300.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever